- Home
- PRSO vs DWTX Comparison
PRSO vs DWTX Comparison
Compare PRSO & DWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRSO
- DWTX
- Stock Information
- Founded
- PRSO 2008
- DWTX 2012
- Country
- PRSO United States
- DWTX United States
- Employees
- PRSO N/A
- DWTX N/A
- Industry
- PRSO Semiconductors
- DWTX
- Sector
- PRSO Technology
- DWTX
- Exchange
- PRSO Nasdaq
- DWTX NYSE
- Market Cap
- PRSO 4.5M
- DWTX 3.8M
- IPO Year
- PRSO 2001
- DWTX N/A
- Fundamental
- Price
- PRSO $1.00
- DWTX $1.87
- Analyst Decision
- PRSO Strong Buy
- DWTX
- Analyst Count
- PRSO 2
- DWTX 0
- Target Price
- PRSO $3.38
- DWTX N/A
- AVG Volume (30 Days)
- PRSO 498.5K
- DWTX 27.8K
- Earning Date
- PRSO 03-17-2025
- DWTX 02-14-2025
- Dividend Yield
- PRSO N/A
- DWTX N/A
- EPS Growth
- PRSO N/A
- DWTX N/A
- EPS
- PRSO N/A
- DWTX N/A
- Revenue
- PRSO $12,728,000.00
- DWTX N/A
- Revenue This Year
- PRSO $9.59
- DWTX N/A
- Revenue Next Year
- PRSO $1.63
- DWTX N/A
- P/E Ratio
- PRSO N/A
- DWTX N/A
- Revenue Growth
- PRSO N/A
- DWTX N/A
- 52 Week Low
- PRSO $0.73
- DWTX $1.62
- 52 Week High
- PRSO $6.91
- DWTX $22.25
- Technical
- Relative Strength Index (RSI)
- PRSO 46.41
- DWTX N/A
- Support Level
- PRSO $0.95
- DWTX N/A
- Resistance Level
- PRSO $1.50
- DWTX N/A
- Average True Range (ATR)
- PRSO 0.19
- DWTX 0.00
- MACD
- PRSO -0.02
- DWTX 0.00
- Stochastic Oscillator
- PRSO 9.09
- DWTX 0.00
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.
About DWTX DOGWOOD THERAPEUTICS INC
Dogwood Therapeutics Inc formerly Virios Therapeutics Inc is a development-stage biotechnology company. It is focused advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia (FM) and Long-COVID (LC). Its product candidates includes IMC-1 and IMC-2, IMC-1, is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.